Renal Dialysis Market size is set to grow by USD 64.3 billion from 2024-2028, Increasing prevalence of kidney diseases boost the market, Technavio
NEW YORK, Aug. 21, 2024 /PRNewswire/ — The global renal dialysis market size is estimated to grow by USD 64.3 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of almost 8.09% during the forecast period. Increasing prevalence of kidney diseases is driving market growth, with a trend towards rising demand for home peritoneal dialysis treatment. However, high treatment costs poses a challenge. Key market players include AngioDynamics Inc., Asahi Kasei Corp., B.Braun SE, Baxter International Inc., Becton Dickinson and Co., DaVita Inc., Dialysis Clinic Inc., Diaverum AB, Fresenius Medical Care AG and Co. KGaA, JMS Co. Ltd., Medtronic Plc, Merck and Co. Inc., Nikkiso Co. Ltd., Nipro Corp., Nxstage Medical Inc., Physidia, Satellite Healthcare Inc., STERIS plc, Toray Industries Inc., and US Renal Care.
Get a detailed analysis on regions, market segments, customer landscape, and companies- View the snapshot of this report
Renal Dialysis Market Scope
Report Coverage
Details
Base year
2023
Historic period
2018 – 2022
Forecast period
2024-2028
Growth momentum & CAGR
Accelerate at a CAGR of 8.09%
Market growth 2024-2028
USD 64.3 billion
Market structure
Fragmented
YoY growth 2022-2023 (%)
7.32
Regional analysis
North America, Asia, Europe, and Rest of World (ROW)
Performing market contribution
Asia at 38%
Key countries
US, Germany, China, Japan, and UK
Key companies profiled
AngioDynamics Inc., Asahi Kasei Corp., B.Braun SE, Baxter International Inc., Becton Dickinson and Co., DaVita Inc., Dialysis Clinic Inc., Diaverum AB, Fresenius Medical Care AG and Co. KGaA, JMS Co. Ltd., Medtronic Plc, Merck and Co. Inc., Nikkiso Co. Ltd., Nipro Corp., Nxstage Medical Inc., Physidia, Satellite Healthcare Inc., STERIS plc, Toray Industries Inc., and US Renal Care
Market Driver
Peritoneal dialysis is a growing treatment option for managing kidney failure by cleaning waste fluid from the blood. This process involves placing a catheter into the abdominal cavity and using a dialysate solution. The solution can be commercially available or homemade using isotonic crystalloid solutions. Training is essential for patients to perform exchanges, maintain sterility, and manage catheter care. Indications include severe metabolic disturbances like hepatic encephalopathy and metabolic acidosis. Peritoneal dialysis’s increasing popularity stems from its affordability and convenience, with over 10% of dialysis patients opting for this method. Technological advances include the development of automated peritoneal dialysis (APD) using programmable machines and advanced dialysis solutions with neutral pH and low glucose degradation products. The availability of these homecare solutions is fueling market growth during the forecast period.
The kidney dialysis industry is experiencing significant growth due to the rising prevalence of kidney diseases, particularly among the aging population and those with diabetes and hypertension. Trends in the market include peritoneal dialysis and portable equipment for increased patient convenience. Technological advancements have led to the development of external blood-cleansing devices and innovative technologies for immune-mediated illnesses. Public healthcare spending and awareness campaigns aim to increase access to dialysis for those in need. Kidney damage from waste build-up due to kidney diseases can lead to high blood pressure, heart disease, stroke, and early death. In the US, over 37 million Americans have chronic kidney disease (CKD), with non-Hispanic Black adults, non-Hispanic Asian adults, and adult Hispanics disproportionately affected. Medical professionals are working to improve the CKD Surveillance System and meet Healthy People objectives through Primary and Secondary Dialysis, including hemodialysis, renal replacement fluids, dialysis machines, dialyzers, and dialysis concentrates. The industrialized world and developing world both face challenges in providing affordable dialysis options, with kidney transplantation remaining the ideal long-term solution for many patients.
Discover 360° analysis of this market. For complete information, schedule your consultation – Book Here!
Market Challenges
The global renal dialysis market faces significant challenges due to the high cost of treatment for end-stage renal disease (ESRD) patients, particularly in low- and middle-income countries. ESRD is a chronic condition that requires frequent and costly dialysis treatments, which can be financially burdensome even for well-established economies. The direct medical costs of dialysis include expenses for staffing, physician fees, dialyzers, tubing, solutions, hospitalization, and capital costs for hemodialysis machines and peritoneal dialysis. Direct non-medical costs consist of facilities, utilities, building costs, and other overhead expenses. Intangible costs include the impact on quality of life, pain, and suffering, while indirect costs involve productivity losses. However, intangible and indirect costs are often overlooked in economic evaluations. In high-income countries, hemodialysis is more expensive than peritoneal dialysis. The escalating costs of renal disease treatment are expected to hinder the growth of the global renal dialysis market, especially in lower-middle-income countries where the majority of the world’s population resides. Government policies regarding insurance coverage and reimbursement for ESRD vary significantly from country to country, further complicating the market landscape.The Renal Dialysis Market faces significant challenges due to the increasing prevalence of renal diseases, particularly chronic kidney disease (CKD), in both the industrialized and developing worlds. CKD is a degenerative disorder affecting millions, with over 800 million people estimated to live with the condition globally. In the US, over 15% of the population, including non-Hispanic Black, White, Asian adults, and adult Hispanics, are affected. CKD leads to kidney damage, resulting in the build-up of waste products in the body, increasing the risk of high blood pressure, heart disease, stroke, and early death. Medical professionals are working to improve CKD surveillance and meet Healthy People objectives through innovative technologies like Primary and Secondary Dialysis. Key products in the Dialysis Market include hemodialysis machines, such as the 4008A, renal replacement fluids, dialysis machines, dialyzers, and dialysis concentrates, as well as dialysis catheters. Obesity and diabetes mellitus are major risk factors for CKD, making population health management crucial.
For more insights on driver and challenges – Request a sample report!
Segment Overview
This renal dialysis market report extensively covers market segmentation by
End-user 1.1 In center dialysis1.2 Home dialysisType 2.1 Hemodialysis2.2 Peritoneal2.3 OthersGeography 3.1 North America3.2 Asia3.3 Europe3.4 Rest of World (ROW)
1.1 In center dialysis- The renal dialysis market is experiencing significant growth due to the increasing prevalence of chronic kidney disease worldwide. Dialysis centers and home care providers are expanding their services to cater to the rising demand. Key players in the market include Fresenius Medical Care, DaVita Inc., and Diaverum. These companies invest in research and development to innovate new technologies and improve patient care. The market is expected to continue growing due to the increasing population with kidney disease and advancements in dialysis treatments.
For more information on market segmentation with geographical analysis including forecast (2024-2028) and historic data (2017-2021) – Download a Sample Report
Research Analysis
The kidney dialysis industry caters to individuals with chronic kidney diseases (CKD), providing essential treatments such as peritoneal dialysis and portable dialysis equipment. Technological advancements continue to revolutionize kidney dialysis, making treatments more accessible and convenient. Kidney diseases, including diabetes and hypertension, are major contributors to the industry’s growth. Public healthcare spending and awareness campaigns play crucial roles in increasing access to kidney dialysis for those in need. Kidney damage from waste products build-up can lead to high blood pressure, heart disease, stroke, and early death. In the United States, over 37 million Americans are estimated to have CKD. Medical professionals play a vital role in diagnosing and managing kidney diseases, ultimately improving patient outcomes and quality of life.
Market Research Overview
The kidney dialysis industry caters to individuals with chronic kidney diseases (CKD), a degenerative disorder affecting 800 million people worldwide. Kidney diseases, including renal disorders and kidney damage from waste build-up, can lead to high blood pressure, heart disease, stroke, and early death. Causes include diabetes mellitus, hypertension, obesity, and immune-mediated illnesses. Peritoneal dialysis, a common treatment, uses the lining of the abdomen to filter waste products. Technological advancements have led to portable dialysis equipment, external blood-cleansing devices, and innovative technologies. Public healthcare spending and awareness campaigns aim to increase access to dialysis treatments, especially in the industrialized world and developing countries. The aging population, particularly non-Hispanic Black adults, non-Hispanic White adults, non-Hispanic Asian adults, and adult Hispanics, are at higher risk. The CKD Surveillance System and Healthy People objectives strive for early detection and prevention. Primary and secondary dialysis, including hemodialysis, employ various tools like renal replacement fluids, dialysis machines, dialyzers, and dialysis concentrates. The market includes dialysis catheters, such as the 4008A dialysis machine, and dialysis machines like hemodialysis. Medical professionals play a crucial role in diagnosing and managing CKD, and the prevalence of CKD continues to rise, increasing the demand for dialysis treatments. The healthcare costs and discretionary income impact access to dialysis, with kidney transplantation remaining the ideal long-term solution for some patients. Veterinary hospitals also use kidney dialysis equipment for treating kidney diseases in animals.
Table of Contents:
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation
End-userIn Center DialysisHome DialysisTypeHemodialysisPeritonealOthersGeographyNorth AmericaAsiaEuropeRest Of World (ROW)
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
View original content to download multimedia:https://www.prnewswire.com/news-releases/renal-dialysis-market-size-is-set-to-grow-by-usd-64-3-billion-from-2024-2028–increasing-prevalence-of-kidney-diseases-boost-the-market-technavio-302226582.html
SOURCE Technavio